HomeCOLL • NASDAQ
Collegium Pharmaceutical Inc
add
$29.34
0.93%
After Hours:(0.00%)0.00
$29.34
Closed: May 15, 4:02:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 177.76M | 22.66% |
Operating expense | 131.90M | 72.42% |
Net income | 2.42M | -91.28% |
Net profit margin | 1.36 | -92.89% |
Earnings per share | 1.49 | 2.76% |
EBITDA | 80.94M | -4.67% |
Effective tax rate | 22.58% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 197.77M | -37.82% |
Total assets | 1.63B | 46.41% |
Total liabilities | 1.40B | 56.59% |
Total equity | 234.43M | — |
Shares outstanding | 32.14M | — |
Price to book | 3.98 | — |
Return on assets | 3.70% | — |
Return on capital | 5.06% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.42M | -91.28% |
Cash from operations | 55.40M | -10.56% |
Cash from investing | -9.68M | 46.60% |
Cash from financing | -25.24M | 53.39% |
Net change in cash | 20.48M | 298.14% |
Free cash flow | 37.78M | -35.46% |
Previous close
$29.07
Day range
$29.19 - $29.80
Year range
$23.23 - $42.29
Market cap
943.05M USD
Avg Volume
370.65K
P/E ratio
24.25
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Website
Employees
357
